5-6 December 2018

London, UK

Speakers

Expand/Collapse

Sukhvinder Sidhu
Global Head of Pharmacology
Sanofi

Tao You
Head of Pharmacokinetic & Pharmacodynamics Modelling Lab
Boehringer Ingelheim

Thomas Jaquin
Immuno-Oncology & Research Scientist
Pieris AG

Dik C. van Gent
Associate Professor
Erasmus MC

Elizabeth Hardaker
Head of Oncology in vivo Pharmacology Group
AstraZeneca

Elizabeth Hardaker did her PhD and post doc in respiratory diseases at the National Heart and Lung Institute (NHLI) Imperial college.  After this Elizabeth moved to Novartis Institute for Biomedical Research in the Respiratory disease area.  Within this job role she developed a wide variety of in vivo models to investigate immune stimulatory agents that would enhance clearance of bacterial and viral infection.  Subsequently Elizabeth moved to Evotec as a group leader where amongst other roles she was biology lead for an immune oncology project.  Elizabeth is now a Team Leader at Astra Zeneca within the oncology in vivo team.  As part of this role Elizabeth supports the strategy to introduce and characterise models to enable the group to actively support immune targeting therapies.

Day One

Wednesday, 6th December 2017

13.55 | Role of Genetically Engineered Mouse Models in Drug Discovery

Anita Seshire, Ph.D
Head of Laboratory, Translational Innovation Platform Oncology
Merck

Biomolecular engineer by training, graduated in pharmacy, expert in cancer stem cells, started with leukemic stem cells research funded by a José Carreras fellowship and now 8 years with Merck Biopharma in cancer stem cells and oncology/ immuno-oncology research.

Day One

Wednesday, 6th December 2017

10.10 | Utilising Multicellular 3D Models for Preclinical Drug Discovery

Shannon Burke
Scientist
Medimmune

Cancer Immunologist with previous experience in lymphocyte development, virus and tumour immunology at the Wellcome Trust Sanger Institute and the Babraham Institute. Now working in pre-clinical oncology at Medimmune, Cambridge. Long-standing interest in complex in vitro systems to better model clinical scenarios.

Day Two

Thursday, 7th December 2017

10.10 | A Slice of Reality: Using Tumour Slices to Study the Tumour Microenvironment